Physician profile
Beth A Gibbons
NPI 1730300716
$1,286.39
in general payments reported to CMS, 2019-2025
14 companies · $1,079 in 2025
The $1,079 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.65 · 2020: $36.68 · 2021: $54.83 · 2022: $29.79 · 2025: $1,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $520.97 | 2025 | Wavewriter Alpha Prime 16, Intracept, General - Therapies |
| Abbott Laboratories | $145.14 | 2025 | Eterna |
| Mml US, INC. | $123.85 | 2025 | Reactiv8 |
| Baxter Healthcare | $117.90 | 2019-2021 | |
| Depuy Synthes Sales INC. | $110.16 | 2025 | Trufill |
| Medtronic, INC. | $57.39 | 2022-2025 | Aquamantys(Tm) |
| Xtant Medical INC | $35.59 | 2025 | |
| Medical Device Business Services, INC. | $33.04 | 2025 | Stratafix |
| Zimmer Biomet Holdings, INC. | $32.20 | 2019 | |
| Brainlab, INC. | $27.06 | 2020-2021 | |
| Davol INC. | $25.22 | 2025 | Arista |
| Saluda Medical Americas, INC. | $22.38 | 2025 | Evoke |
| Stryker Corporation | $20.10 | 2025 | Spinejack, Optablate, Mild Device Kit |
| Curonix LLC | $15.39 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Gibbons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.